Navigation Links
Simbionix Launches Innovative Patient-Specific Simulation
Date:10/3/2008

CLEVELAND, Ohio, October 3 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, advances procedural simulation from theoretical promise to operating room reality.

The PROcedure Rehearsal Studio(TM), Simbionix' latest innovative medical simulation system, is the world's first medical simulator that enables clinicians to create practice scenarios based on their patient's unique pathology and anatomy.

Dr. Karl Illig, Chief of Vascular Surgery at Strong Medical Center in Rochester, NY, explains why physicians are eager to start using the new simulator: "PROcedure Studio helps us identify pitfalls and problems and solve them on the machine. If we're going to make a mistake, let's make it on the simulators first."

Gary Zamler, CEO of Simbionix, sees the launch of Procedure as "a quantum leap in the world of medical simulation that has the potential to significantly improve patient outcomes while reducing health care costs."

"Our leading technology has made Simbionix the industry leader in medical simulation. PROcedure Rehearsal Studio shows where that leadership will be taking everyone."

Mr. Zamler also announced that Strong Medical Center in Rochester, NY, Imperial College, UK, and Sheba Hospital, Israel have already signed agreements with Simbionix to use PROcedure Rehearsal Studio in their simulation centers.

"These leading hospitals will use and test PROcedure Rehearsal Studio in accordance with Simbionix' philosophy and mission to collaborate with the medical community developing leading-edge technologies for training and education while promoting patient safety."

Simbionix will unveil this next generation of medical simulation on October 12th at the Annual Transcatheter Cardiovascular Therapeutic symposium (TCT) in Washington, DC.

Company Description

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures.
http://www.simbionix.com

Contact:

Inbal Mazor

VP Marketing

Simbionix

inbal@simbionix.com

Tel: +972-8-9211177


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
2. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
3. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
4. CISBIO Bioassays Launches Chromoa(TM) Chromogranin A ELISA Kit
5. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
6. Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit
7. Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
8. Lena Chow, Veteran Biotech Marketer, Launches New Website
9. BioSpace Launches Life Science Career Content and Resources from the Biotech Work Portal
10. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
11. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences , ... life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer ... “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to ...
Breaking Biology Technology:
(Date:4/24/2017)... , April 24, 2017 Janice ... partner with  Identity Strategy Partners, LLP (IdSP) , ... or without President Trump,s March 6, 2017 ... Entry , refugee vetting can be instilled with greater ... (Right now, all refugee applications are suspended by ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
Breaking Biology News(10 mins):